High level of HIV viral suppression in a cross-sectional study of Ugandan men with urethritis and bacterial STI.

HIV viral suppression, urethral discharge syndrome Uganda antiretroviral therapy resistance factors associated with HIV transmission men risk behaviours sexually transmitted infections

Journal

International journal of STD & AIDS
ISSN: 1758-1052
Titre abrégé: Int J STD AIDS
Pays: England
ID NLM: 9007917

Informations de publication

Date de publication:
12 2023
Historique:
medline: 15 11 2023
pubmed: 7 8 2023
entrez: 6 8 2023
Statut: ppublish

Résumé

Urethritis associated with non-viral sexually transmitted infections (STI) increases the risk of HIV acquisition and transmission in those living with HIV (LWH) without viral load suppression (VLS). Compared to women, men typically have lower rates of HIV VLS. We assessed the prevalence of VLS and drug resistance mutations in men LWH and urethral discharge syndrome (UDS) in Kampala, Uganda. Men with UDS were recruited in Kampala October 2019-November 2020. Medical, demographic, and behavioural data were collected with biological samples. All reactive HIV results (rapid, sequential algorithm) underwent confirmatory HIV antibody- and HIV incidence-testing, and viral load (VL) measurement. The 50 of 250 participants (20%) had reactive HIV rapid tests and 48/50 (96%) were aware of their HIV status and using antiretroviral therapy (ART). The median age was 38 years (IQR 32-45), 27/50 (54%) had engaged in transactional sex, and 30/50 (60%) reported alcohol before sex. VLS was present in 46/50 (92%). There were no major resistance mutations present in any samples analyzed. The prevalence of HIV and VLS was greater in these men than in the general Ugandan adult population. Most men LWH were on ART and thus less likely to transmit HIV despite demonstrating sexual behaviours associated with high-risk of STIs. These data emphasize that high levels of ART coverage and VLS are achievable among men with UDS in urban Kampala.

Sections du résumé

BACKGROUND
Urethritis associated with non-viral sexually transmitted infections (STI) increases the risk of HIV acquisition and transmission in those living with HIV (LWH) without viral load suppression (VLS). Compared to women, men typically have lower rates of HIV VLS. We assessed the prevalence of VLS and drug resistance mutations in men LWH and urethral discharge syndrome (UDS) in Kampala, Uganda.
METHODS
Men with UDS were recruited in Kampala October 2019-November 2020. Medical, demographic, and behavioural data were collected with biological samples. All reactive HIV results (rapid, sequential algorithm) underwent confirmatory HIV antibody- and HIV incidence-testing, and viral load (VL) measurement. The
RESULTS
50 of 250 participants (20%) had reactive HIV rapid tests and 48/50 (96%) were aware of their HIV status and using antiretroviral therapy (ART). The median age was 38 years (IQR 32-45), 27/50 (54%) had engaged in transactional sex, and 30/50 (60%) reported alcohol before sex. VLS was present in 46/50 (92%). There were no major resistance mutations present in any samples analyzed.
CONCLUSIONS
The prevalence of HIV and VLS was greater in these men than in the general Ugandan adult population. Most men LWH were on ART and thus less likely to transmit HIV despite demonstrating sexual behaviours associated with high-risk of STIs. These data emphasize that high levels of ART coverage and VLS are achievable among men with UDS in urban Kampala.

Identifiants

pubmed: 37544771
doi: 10.1177/09564624231193491
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

998-1003

Subventions

Organisme : NIBIB NIH HHS
ID : U54 EB007958
Pays : United States

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Evan J Beck (EJ)

Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Oliver Laeyendecker (O)

Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Sharada Saraf (S)

Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Swetha Ashokkumar (S)

Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Annet Onzia (A)

Infectious Disease Institute, Makerere University, Kampala, Uganda.

Johan H Melendez (JH)

Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Justin Chan (J)

Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Peter Kyambadde (P)

STD and AIDS Control Programme, Ministry of Health of Uganda, Kampala, Uganda.

Ethan Gough (E)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Rosalind Parkes-Ratanshi (R)

Infectious Disease Institute, Makerere University, Kampala, Uganda.

Yukari C Manabe (YC)

Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Infectious Disease Institute, Makerere University, Kampala, Uganda.

Matthew M Hamill (MM)

Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH